首页> 外国专利> Compounds as modulators of PGD2 receptors and / or CRTH2 and their use in treating asthma and allergic inflammation

Compounds as modulators of PGD2 receptors and / or CRTH2 and their use in treating asthma and allergic inflammation

机译:用作PGD2受体和/或CRTH2调节剂的化合物及其在治疗哮喘和过敏性炎症中的用途

摘要

Compound having the formula II: or a salt or solCompuesto having the formula II: or a pharmaceutically acceptable salt or solvate thereof, in pharmaceutically acceptable dude thereof, the Queb is a ring fused 5-membered conqueB is a ring fused 5-membered ring containing 0, 1, 2 or 3 heteroatoms selected from N, having 0, 1, 2 or 3 heteroatoms selected from N, O and S; optionally, B is substituted with Haloge O yS; optionally, B is substituted by halogen, (C1-C3), (C1-C3), cicloalqno, (C1-C3), (C1-C3) alkyl, (C3-C5) cycloalkyl, (C3-C5 ), Uilo aminoalkyl (C3-C5) cycloalkyl, (C3-C5), alkylamino (C1-C3), hydroxyl, oxo, -OR ', -CONR'R ", -N (R") C (O (C1- C3), hydroxyl, oxo, -OR ', -CONR'R ", -N (R") C (O) R', -CO2R ', -CN, aryl or heteroaryl; X is a inthe) R', - CO2R ', -CN, aryl or heteroaryl; X is a divalent linkage selected from -O-, -S (O) k-, -CRaRb-ce divalent selected from -O-, -S (O) k-, -CRaRb-, -C (O) -, - and NR 8 -C (NR9) -; Y is a divalen bond, -C (O) -, -NR8- and -C (NR9) -; Y is a divalent linkage selected -SO2NH-, -SO2NMe-, -C (O) NH-, -SO2NH- -nte selected, -SO2NMe-, -C (O) NH-, -NH-, -NHCO2- and -NHC (O) -NMe; Z is -CO2R12, -C (O) NR12H-, -NHCO2- and -NHC (O) -NMe; Z is -CO2R12, -C (O) NR12R13 or heteroaryl; L is a divalent linking seleccR13 or heteroaryl; L is a divalent linkage selected from methylene, ethylene, chloromethylene, hidroxionado methylene, ethylene, chloromethylene, hydroxymethylene and methylmethylene; R2 is a ring bencimetileno and methylmethylene; R2 is a benzene ring which is unsubstituted or substituted with hay which is unsubstituted or substituted with halogen, -OR 'or -R', wherein R 'is alkyl (C1-C8alógeno, -OR' or - R ', wherein R' is (C1-C8) -alkyl or (C1-C8); R5 and R6 are independent) -alkyl or (C1-C8); R5 and R6 are independently hydrogen, halogen, (C1-C8) fluoromente hydrogen, halogen, (C1-C8) fluoroalkyl (C1-C4) heteroalkyl, (C2-C8), aryl, hetealquilo (C1-C4) heteroalkyl, (C2-C8), aryl, heteroaryl, aryl (C1-C4) alkyl, -NR'R ", -OR ', -NO2, roarilo, aryl (C1-C4) alkyl, -NR'R", -OR' , -NO2, -CN, -C (O) R ', -CO2R', -C (O) NR'R ", (C1-C4) - CN, -C (O) R ', -CO2R' , -C (O) NR'R ", (C1-C4) -C (O) NR'R", -S (O) mR ', -S (O) k NR'R ", -OC (O) OR ', -OC (OC (O) NR'R ", -S (O) mR', -S (O) k NR'R", -OC (O) OR ', -OC (O) R', - OC (O) NR'R ", N (R '') C (O) NR'R", -N (R ") C (O) R ', -) R', -OC (O) NR ' R ", N (R '') C (O) NR'R", -N (R ") C (O) R ', -N (R") S (O) kR' or -N (R " ) C (O) OR '; R8, R10 and R11 are InN (R ") S (O) kR 'or -N (R") C (O) OR'; R8, R10 and R11 are independently hydrogen, (C1-C8) fluordependientemente hydrogen, (C1-C8) fluoroalkyl (C1-C4) heteroalkyl, (C2-C8), aryl, hetoalquilo (C1-C4) heteroalkyl, (C2-C8), aryl, heteroaryl, aryl (C1-C4), -C (O) R ', -CO2R', -Ceroarilo, aryl (C1-C4), -C (O) R ', -CO2R' , -C (O) NR'R ", -S (O) mR 'or -S (O) k NR'R"; R9 is hydrogen, (O) NR'R ", -S (O) mR' or - S (O) k NR'R "; R9 is hydrogen, (C1-C6) heteroalkyl, (C2-C6), arilalquilalquilo (C1-C6) heteroalkyl, (C2-C6), aryl- (C1-C4), -OR 'or -NR'R "; R12 and R13 are independieno (C1-C4), -OR' or -NR'R"; R12 and R13 are independently hydrogen, (C1-C6) heteroalkyl temente hydrogen, (C1 C6) heteroalkyl, (C2-C6), aryl, aryl (C1-C4) or heteroaryl; (C2-C6), aryl, aryl (C1-C4) or heteroaryl; each R14 is independently halogen, alkyl (each R14 is independently halogen, (C1-C8) fluoroalkyl (C1-C4) alkyl, (C2-C5), C1-C8) fluoroalkyl (C1-C4) alkyl, (C2 -C 5), -OR ', -NR'R ", -NO2, -CN, -C (O) R' or aryl; Ra and Rb so-oR ', NR'R", -NO 2, -CN, -C (O) R 'or aryl; Ra and Rb are independently hydrogen, (C1-C6) independently hn hydrogen, (C1-C6) heteroalkyl, (C2-C6), aryl- (C1-C4), -OR 'or-eteroalquilo (C2-C6) , aryl (C1-C4), -OR 'or -NR'R "; each R', R" and R '' 'is independently hiNR'R "; each R', R" and R '' 'is independently hydrogen , (C1-C6) alkyl, (C3C8) cidrógeno, (C1-C6) alkyl, (C3C8) cycloalkyl (C3C8), aryl or aryl (C1-C4); ecloalquenilo (C3C8), aryl or aryl (C1-C4); the subscript k is 0, 1 or 2; the subscript m is 0, 1, l subscript k is 0, 1 or 2; the subscript m is 0, 1, 2 or 3; and the subscript n is 0, 1, 2, 3 or 4. 2 or 3; and the subscript n is 0, 1, 2, 3 or 4.
机译:具有式II的化合物:或其盐或溶胶具有式II的化合物或其药学上可接受的盐或溶剂化物:在其药学上可接受的范围内,Queb是稠合的5元环稠环,B是稠合的5元环稠环选自N的0、1、2或3个杂原子,具有选自N,O和S的0、1、2或3个杂原子;任选地,B被Haloge O yS取代;任选地,B被卤素,(C 1 -C 3),(C 1 -C 3),环氯基,(C 1 -C 3),(C 1 -C 3)烷基,(C 3 -C 5)环烷基,(C 3 -C 5),硅烷基氨基烷基取代(C3-C5)环烷基,(C3-C5),烷基氨基(C1-C3),羟基,氧代,-OR',-CONR'R“,-N(R”)C(O(C1-C3),羟基,氧代,-OR',-CONR'R“,-N(R”)C(O)R',-CO2R',-CN,芳基或杂芳基; X是其中的R',-CO2R',- CN,芳基或杂芳基; X是选自-O-,-S(O)k-,-CRaRb-ce的二价键-ce选自-O-,-S(O)k-,-CRaRb-,-C(O)-,-的二价键和NR 8 -C(NR9)-; Y为二烯键,-C(O)-,-NR8-和-C(NR9)-; Y是选择的-SO2NH-,-SO2NMe-,-C(O)NH-,-SO2NH- -nte的二价键,-SO2NMe-,-C(O)NH-,-NH-,-NHCO2-和- NHC(O)-NMe; Z为-CO 2 R 12,-C(O)NR 12 H-,-NHCO 2-和-NHC(O)-NMe; Z为-CO 2 R 12,-C(O)NR 12 R 13或杂芳基; L是二价连接的seleccR13或杂芳基; L是选自亚甲基,亚乙基,亚氯甲基,高碘亚甲基,亚乙基,亚氯甲基,羟亚甲基和亚甲基亚甲基的二价键; R 2是环苯甲腈基和甲基亚甲基; R 2是未被取代或被卤素取代的干草环,未被取代或被卤素,-OR'或-R'取代,其中R'是烷基(C1-C8alogeno,-OR'或-R',其中R'是(C1-C8)-烷基或(C1-C8); R5和R6独立)-烷基或(C1-C8); R 5和R 6独立地是氢,卤素,(C 1 -C 8)氟代氢,卤素,(C 1 -C 8)氟烷基(C 1 -C 4)杂烷基,(C 2 -C 8),芳基,杂芳基(C 1 -C 4)杂烷基,(C 2 -C8),芳基,杂芳基,芳基(C1-C4)烷基,-NR'R“,-OR',-NO2,roarilo,芳基(C1-C4)烷基,-NR'R”,-OR',- NO2,-CN,-C(O)R',-CO2R',-C(O)NR'R“,(C1-C4)-CN,-C(O)R',-CO2R',-C( O)NR'R“,(C1-C4)-C(O)NR'R”,-S(O)mR',-S(O)k NR'R“,-OC(O)OR',- OC(OC(O)NR'R“,-S(O)mR',-S(O)k NR'R”,-OC(O)OR',-OC(O)R',-OC(O )NR'R“,N(R))C(O)NR'R”,-N(R“)C(O)R',-)R',-OC(O)NR'R”,N (R'')C(O)NR'R“,-N(R”)C(O)R',-N(R“)S(O)kR'或-N(R”)C(O)要么 '; R8,R10和R11是InN(R″)S(O)kR′或-N(R″)C(O)OR′; R 8,R 10和R 11独立地是氢,(C 1 -C 8)氟依赖性氢,(C 1 -C 8)氟烷基(C 1 -C 4)杂烷基,(C 2 -C 8),芳基,杂芳基(C 1 -C 4)杂烷基,(C 2 -C 8) ),芳基,杂芳基,芳基(C1-C4),-C(O)R',-CO2R',-Ceroarilo,芳基(C1-C4),-C(O)R',-CO2R'和-C( O)NR'R“,-S(O)mR'或-S(O)k NR'R”; R9是氢,(O)NR'R”,-S(O)mR'或-S(O)kNR'R”; R 9为氢,(C 1 -C 6)杂烷基,(C 2 -C 6),芳基芳基(C 1 -C 6)杂烷基,(C 2 -C 6),芳基-(C 1 -C 4),-OR'或-NR'R“; R 12和R13是独立的(C1-C4),-OR'或-NR'R”; R 12和R 13独立地是氢,(C 1 -C 6)杂烷基氢,(C 1 -C 6)杂烷基,(C 2 -C 6),芳基,芳基(C 1 -C 4)或杂芳基; (C2-C6),芳基,芳基(C1-C4)或杂芳基;每个R 14独立地为卤素,烷基(每个R 14独立地为卤素,(C 1 -C 8)氟烷基(C 1 -C 4)烷基,(C 2 -C 5,C 1 -C 8)氟烷基(C 1 -C 4)烷基,(C 2 -C 5 ),-OR',-NR'R“,-NO2,-CN,-C(O)R'或芳基; Ra和Rb so-oR',NR'R”,-NO 2,-CN,-C (O)R'或芳基; Ra和Rb独立地是氢,(C1-C6)独立地是氢,(C1-C6)杂烷基,(C2-C6),芳基-(C1-C4),-OR'或-叔烷基(C2-C6),芳基(C1-C4),-OR'或-NR'R“;每个R',R”和R“'独立地为hiNR'R”;每个R',R“和R”'独立地为氢,( C 1 -C 6)烷基,(C 3 C 8)香茅基,(C 1 -C 6)烷基,(C 3 C 8)环烷基(C 3 C 8),芳基或芳基(C 1 -C 4); ecloalquenilo(C3C8),芳基或芳基(C1-C4);下标k为0、1或2;下标m为0、1,l下标k为0、1或2;下标m为0、1、2或3;下标n为0、1、2、3或4。2或3;下标n为0、1、2、3或4。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号